1st GIE – May 30-31, 2025

The GIE is a new and original initiative from OESO.

For 36 hours, specialists of the highest level will meet in one room to listen to and discuss 36 presentations on a single topic. 

This 36 hour (2 nights) event will offer
an experience which will foster exchanges
and interaction among a group of KOLs
(key opinion leaders), in an informal
country setting, the "Abbaye de Royaumont",
a 13th Century Cistercian Abbey located in
the heart of a forest, only 29 km from Paris. 
May 30 and 31, 2025                                      

To our knowledge, this will be
a first-of-its-kind event.

Here below is the preliminary program.
 
We are looking forward to welcoming you to this event.
For futher information, please contact: gie@oeso.org
 

  • Robert Giuli, MD, FACS, FCCP, Professor of Surgery, Founder & Deputy Executive Director of OESO  
    robert.giuli@oeso.org                                                                                                
  • Nikki Johnston, Professor of Otolaryngology, Governor of the OESO-SEMPIRE Platform
    NJohnston@mcw.edu
  • C. Prakash Gyawali, MD, FRCP, Professor of Medicine, Washington University in St. Louis                   cprakash@wustl.edu

Preliminary program

Day 1

2:30 pm – Introduction to the novel format

3:00-4:30 pm – Session 1:
Current and novel diagnostics

Chairs:

  • Chat session panel (30 minutes)
  • Questions (5 minutes each)
  1. Mucosal impedance measurements in diagnosing and phenotyping reflux
  2. Non-invasive markers for reflux diagnosis (salivary biomarkers)
  3. Catheter-based vs. wireless reflux monitoring
  4. Role of endoscopy in reflux diagnosis
  5. How to diagnose EGJ disruption and hiatus hernia (Hill vs AFS grade)
  6. Innovation: Development and assessment of a daily reflux symptom diary as a fit-for-purpose clinical outcomes assessment tool to assess LPR symptom severity and its treatment response
  • Discussion (30 minutes)

5:00-6:30 pm – Session 2:
Leveraging new acid suppressants in reflux management

Chairs:

  • Chat session panel (30 minutes)
  • Questions (5 minutes each)
  1. P-CABs: a new avenue in acid suppression
  2. Optimizing PPI and H2RA use in reflux disease
  3. When to consider PCABs in reflux management
  4. Safety profile and side effects of acid suppressants
  5. On demand vs. daily acid suppressants: when and which agents
  6. Innovation: Esophageal clearance mechanisms following reflux episodes
  • Discussion (30 minutes)

Day 2

9:00-10:30 am – Session 3:
Adjunctive medical management: Mucosal protectants, Reflux reducers, Neuromodulators

Chairs:

  • Chat session panel (30 minutes)
  • Questions (5 minutes each)
  1. Behavioral and lifestyle approaches
  2. Reflux reducing agents (baclofen, bethanechol, others)
  3. Mucosal protective compounds for treatment of GERD
  4. Status of pepsin inhibitors for PPI refractory GERD and LPR
  5. When are neuromodulators needed in symptomatic reflux disease
  6. Innovation: What are the roles of sodium alginates and amprenavir against pepsin-mediated esophageal and laryngeal damage?
  • Discussion (30 minutes)

11:00-12:30 pm – Session 4:
Advances in invasive reflux management

Chairs:

  • Chat session panel (30 minutes)
  • Questions (5 minutes each)
  1. TIF and C-TIF
  2. Magnetic sphincter augmentation
  3. Reflux stop
  4. Bariatric approaches to managing reflux disease
  5. Complications of invasive anti-reflux therapy
  6. Innovation: Obesity treatment and reflux
  • Discussion (30 minutes)

2:00-3:30 pm – Session 5:
Role of reflux in extra-esophageal syndromes

Chairs:

  • Chat session panel (30 minutes)
  • Questions (5 minutes each)
  1. How is pharyngeal reflux diagnosed?
  2. Laryngo-pharyngeal symptoms and Laryngopharyngeal reflux disease
  3. Reflux and voice disorders
  4. Reflux and pulmonary disease
  5. Reflux and lung transplant outcomes
  6. Innovation: Reflux vs oropharyngeal dysphagia in pediatric aerodigestive disease
  • Discussion (30 minutes)

4:00-5:30 pm – Session 6:
Modern diagnosis of esophageal and laryngeal reflux syndromes

Chairs:

  • Chat session panel (30 minutes)
  • Questions (5 minutes each)
  1. Modern diagnosis of GERD: Lyon Consensus 2.0
  2. Modern diagnosis of LPRD
  3. Behavioral syndromes in the evaluation of GERD (belching disorders, rumination)
  4. Esophageal Motility Disorders related to GERD
  5. Provocative maneuvers and scoring systems predictive of GERD
  6. Innovation: Proximal esophageal metrics and contractile reserve in LPR
  • Discussion (30 minutes)

5:45-6:30 pm: Wrap-up Session